SCHEMBL22758549

SCHEMBL22758549

CCOC1(C)CCN(C(C)=O)CC1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ TSHR P16473 4/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ CYP2D6 P10635 4/20 0.37
▸ EPHX2 P34913 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ PIK3CD O00329 1/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CYP4F2 P78329 1/20 0.35
▸ CYP4A11 Q02928 1/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ CYP2C9 P11712 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12045659 0.78 CYP1A2 (0.43) SMN1; SMN2TSHRCYP1A2TDP1CYP2D6
SCHEMBL29265194 0.77 SMN1; SMN2 (0.36) SMN1; SMN2TSHRCYP1A2TDP1CYP2D6
SCHEMBL24597128 0.76 EPHX2 (0.42) SMN1; SMN2TSHRCYP1A2TDP1CYP2D6
SCHEMBL13819952 0.75 CYP1A2 (0.44) SMN1; SMN2TSHRCYP1A2TDP1CYP2D6
SCHEMBL26620243 0.74 SMN1; SMN2 (0.39) SMN1; SMN2TSHRCYP1A2TDP1CYP2D6
SCHEMBL5949770 0.74 SMN1; SMN2 (0.44) SMN1; SMN2TSHRCYP1A2TDP1KDM4E
SCHEMBL14417843 0.74 CYP1A2 (0.43) SMN1; SMN2TSHRCYP1A2TDP1CYP2D6
SCHEMBL13804292 0.74 CYP1A2 (0.43) SMN1; SMN2TSHRCYP1A2TDP1CYP2D6
SCHEMBL28996429 0.73 CYP1A2 (0.39) SMN1; SMN2TSHRCYP1A2TDP1CYP2D6
SCHEMBL26806869 0.73 SMN1; SMN2 (0.39) SMN1; SMN2CYP1A2TDP1CYP2D6EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020245664-A1 N-(5-(6-ETHOXYPYRAZIN-2-YL)PYRIDIN-2-YL)-4-(2-(METHYLSULFONAMIDO)PYRIMIDIN-4-YL) TETRAHYDRO-2H-PYRAN-4-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS HUMAN CTPS1 INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES STEP PHARMA S.A.S. (FR) 2020-12-10 — — WO disclosed
Send feedback